These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8326983)

  • 21. Early patency in acute myocardial infarction.
    Belenkie I
    Can J Cardiol; 1993 Mar; 9(2):149-51. PubMed ID: 8490781
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comments on the article "Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis" by Golán et al].
    Vlcek J
    Vnitr Lek; 2003 Feb; 49(2):87-8. PubMed ID: 12728569
    [No Abstract]   [Full Text] [Related]  

  • 23. Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction.
    McGahan L
    Issues Emerg Health Technol; 2001 Jan; (13):1-6. PubMed ID: 11902221
    [No Abstract]   [Full Text] [Related]  

  • 24. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Massel D; Gill JB; Cairns JA
    Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thrombolytic therapy in acute myocardial infarction].
    Pedersen TR
    Tidsskr Nor Laegeforen; 1994 May; 114(14):1646-7. PubMed ID: 8079271
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombolytic therapy for acute myocardial infarction.
    Clem JR
    S D J Med; 1994 Jan; 47(1):27-8. PubMed ID: 8122094
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal angiomyolipoma presenting as a retroperitoneal mass following thrombolytic therapy for acute myocardial infarction.
    Kaplan SA; Kohn I; Amis ES; O'Toole KM; Bixon R; Giella J
    N Y State J Med; 1992 May; 92(5):217-9. PubMed ID: 1614675
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project.
    Wailoo A; Goodacre S; Sampson F; Alava MH; Asseburg C; Palmer S; Sculpher M; Abrams K; de Belder M; Gray H
    Heart; 2010 May; 96(9):668-72. PubMed ID: 19508972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case report. Thrombolytic therapy 17 hours after acute myocardial infarct: assessing myocardial viability with 201 thallium imaging].
    Lund GK; Koschyk DH; Nienaber CA
    Herz; 1994 Feb; 19(1):65-8. PubMed ID: 8150415
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombolytic therapy of acute heart infarct].
    Arnold AE; Simoons ML; Lubsen J
    Ned Tijdschr Geneeskd; 1989 Feb; 133(7):335-8. PubMed ID: 2494462
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Friedman HS
    N Engl J Med; 1994 Feb; 330(7):504; author reply 505-6. PubMed ID: 8289861
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
    Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C
    Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute myocardial infarct: thrombolysis of coronary angioplasty?].
    Rickenbacher P
    Praxis (Bern 1994); 1998 Feb; 87(6):183-5. PubMed ID: 9531811
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
    Goel V; Naylor CD
    Can J Cardiol; 1992; 8(1):31-8. PubMed ID: 1617509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reducing mortality in myocardial infarction: goal should be interhospital transfer for primary angioplasty.
    Ivanusa M
    BMJ; 2005 May; 330(7502):1271. PubMed ID: 15920138
    [No Abstract]   [Full Text] [Related]  

  • 37. Thrombolytic treatment for acute myocardial infarction.
    Kleiman N; Roberts R; Pratt C
    Tex Med; 1988 Oct; 84(10):27-32. PubMed ID: 3148205
    [No Abstract]   [Full Text] [Related]  

  • 38. [The search for the best reperfusion therapy in the treatment of acute myocardial infarct. An editorial on the article by Golán L. et al: "Comparison of cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis"].
    Janousek S
    Vnitr Lek; 2003 Feb; 49(2):88-90. PubMed ID: 12728570
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center: the Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study.
    Machecourt J; Bonnefoy E; Vanzetto G; Motreff P; Marlière S; Leizorovicz A; Allenet B; Lacroute JM; Cassagnes J; Touboul P
    J Am Coll Cardiol; 2005 Feb; 45(4):515-24. PubMed ID: 15708697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction.
    Selmer R; Halvorsen S; Myhre KI; Wisløff TF; Kristiansen IS
    Scand Cardiovasc J; 2005 Oct; 39(5):276-85. PubMed ID: 16269397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.